Accord Healthcare, Inc.: Levothyroxine Sodium Tablets, Usp, 25 Mcg (0.025 Mg), 1000-count Bottles

Levothyroxine Sodium Tablets Recall Summary Accord Healthcare is recalling 1,000-count bottles of Levothyroxine Sodium Tablets, 25 mcg, distributed nationwide because the tablets are subpotent—meaning they contain less active ingredient than they should. This affects prescriptions filled across all U.S. states and Washington, D.C. The tablets were manufactured by Intas Pharmaceuticals Limited in India and distributed under the NDC number 16729-447-17.

Recalling firm

ACCORD HEALTHCARE, INC.

Product

Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg), 1000-count bottles, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-447-17.

Reason

Subpotent Drug

Classification

Class II

Category

drug recall

Country

United States

Agency

U.S. Food and Drug Administration

Recall date

2026-08-06

Status

Ongoing

Areas affected

AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, ...

Distribution

Nationwide within the United States

Official recall notice from U.S. Food and Drug Administration

Recall details on Nibble Recalls: https://trynibble.app/recalls/614c4260-dc26-4b64-ae5d-ef1d6d6590b0